0001127602-22-004987.txt : 20220215 0001127602-22-004987.hdr.sgml : 20220215 20220215161342 ACCESSION NUMBER: 0001127602-22-004987 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220212 FILED AS OF DATE: 20220215 DATE AS OF CHANGE: 20220215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kramer Robin CENTRAL INDEX KEY: 0001609222 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 22639313 MAIL ADDRESS: STREET 1: 999 VANDERBILT BEACH ROAD STREET 2: 3RD FLOOR CITY: NAPLES STATE: FL ZIP: 34109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC. DATE OF NAME CHANGE: 20070427 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-12 0000875045 BIOGEN INC. BIIB 0001609222 Kramer Robin 225 BINNEY STREET CAMBRIDGE MA 02142 1 Chief Accounting Officer Common Stock 2022-02-12 4 M 0 99 0 A 1453.348 D Common Stock 2022-02-12 4 F 0 35 214.59 D 1418.348 D Common Stock 2022-02-12 4 M 0 176 0 A 1594.348 D Common Stock 2022-02-12 4 F 0 51 214.59 D 1543.348 D Common Stock 2022-02-12 4 F 0 85 214.59 D 1458.348 D Restricted Stock Unit 0 2022-02-12 4 M 0 99 0 D 2022-02-12 Common Stock 99 189 D Restricted Stock Unit 0 2022-02-12 4 J 0 189 0 D 2022-02-12 Common Stock 189 0 D Restricted Stock Unit 0 2022-02-12 4 M 0 176 0 D 2023-02-12 Common Stock 176 832 D Restricted Stock Unit 0 2022-02-12 4 J 0 326 0 D 2023-02-12 Common Stock 326 506 D Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 21, 2022. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. /s/ Wendell Taylor, attorney-in-fact for Robin Kramer 2022-02-15